Agios Pharmaceuticals, Inc. (AGIO) vs Urogen Pharma (URGN)
Agios Pharmaceuticals, Inc. and Urogen Pharma are both Biotechnology companies. Agios Pharmaceuticals, Inc. and Urogen Pharma are of similar size ($2.0B and $2.0B). Agios Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 140.6% against 100.3%. Urogen Pharma has the higher net margin (−51.7% vs −418.2%) and the higher return on invested capital (0.00% vs −70.2%). Across the 17 metrics below, Urogen Pharma leads on 13 and Agios Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | AGIO | URGN | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.99% | 90.85% | 65.16% |
| Operating margin | (466.78%) | (35.32%) | 0.00% |
| Net margin | (418.24%) | (51.73%) | 0.00% |
| Free cash flow margin | (371.43%) | (84.32%) | 0.00% |
| Return on equity | (34.34%) | 86.49% | (57.72%) |
| Return on assets | (31.89%) | (42.33%) | (49.22%) |
| Return on invested capital | (70.24%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack